The project will be ointly with US Vical Inc. which has proprietary gene transfer technology into the liver cell, and is in a preclinical stage. The concept is based on plasmid DNA which feeds into hepatocytes.
Anges MG news release, April 4, 2017
The project will be ointly with US Vical Inc. which has proprietary gene transfer technology into the liver cell, and is in a preclinical stage. The concept is based on plasmid DNA which feeds into hepatocytes.
Anges MG news release, April 4, 2017